Metronidazole 400mg clinical trials

Combination Study of Antibiotics With Enzalutamide (PROMIZE)

This study, called PROMIZE, is looking at a new combination treatment for advanced prostate cancer that has spread and no longer responds to usual hormone therapy. It combines a standard prostate cancer drug (enzalutamide) with a mix of antibiotics to see if this new approach is safe and effective.